BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 17954292)

  • 1. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
    Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
    Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome.
    Kovesdy CP; Anderson JE; Kalantar-Zadeh K
    J Am Soc Nephrol; 2007 Jan; 18(1):304-11. PubMed ID: 17167114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.
    Hwang SJ; Yang WC; Lin MY; Mau LW; Chen HC;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2616-24. PubMed ID: 20519231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival.
    Bechtel JF; Detter C; Fischlein T; Krabatsch T; Osswald BR; Riess FC; Scholz F; Schönburg M; Stamm C; Sievers HH; Bartels C
    Ann Thorac Surg; 2008 Jan; 85(1):147-53. PubMed ID: 18154800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.
    Götz AK; Böger CA; Hirschmann C; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):155-60. PubMed ID: 15946911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
    Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M
    Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
    Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
    Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimbürger O; Berglund L; Bárány P; Rutkowski B; Lindholm B; Stenvinkel P
    J Intern Med; 2009 Jun; 265(6):708-16. PubMed ID: 19298498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and former smoking increases mortality in patients on peritoneal dialysis.
    Braatvedt GD; Rosie B; Bagg W; Collins J
    N Z Med J; 2006 May; 119(1234):U1977. PubMed ID: 16718288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring relative mortality and epoetin alfa dose among hemodialysis patients.
    Bradbury BD; Wang O; Critchlow CW; Rothman KJ; Heagerty P; Keen M; Acquavella JF
    Am J Kidney Dis; 2008 Jan; 51(1):62-70. PubMed ID: 18155534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
    Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
    J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and its change predict survival in incident dialysis patients.
    Miskulin DC; Meyer KB; Martin AA; Fink NE; Coresh J; Powe NR; Klag MJ; Levey AS;
    Am J Kidney Dis; 2003 Jan; 41(1):149-61. PubMed ID: 12500232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.